5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo. - Bersani,G.; Grispini,A.; Marini,S.; Pasini,A.; Valducci,M.; Ciani,N. (Clin Neuropharmacol, 1990)